OmniAb OABI
NASDAQ OABI
$4.69 +0.10 (+2.18%)
At close: Oct 19, 2026 · 4:00 PM EDT

OmniAb (OABI) Long-Term Debt Issuances (2021 - 2022)

Updated

OmniAb's Long-Term Debt Issuances was $250,000 in Q2 2022, down 50.0% from the prior quarter.

Analysis

OmniAb (OABI) Long-Term Debt Issuances (2021 - 2022) Analysis & Trends

For FY2021, Long-Term Debt Issuances at OmniAb came in at $175,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 OmniAb 603.40 Mn 388.81 Mn 12.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 250,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 55,725.00
API Access

OmniAb Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=OABI&period=max&api_key=YOUR_API_KEY